Literature DB >> 10623653

The paraffin-embedded tissue blot detects PrP(Sc) early in the incubation time in prion diseases.

W J Schulz-Schaeffer1, S Tschöke, N Kranefuss, W Dröse, D Hause-Reitner, A Giese, M H Groschup, H A Kretzschmar.   

Abstract

With the appearance of bovine spongiform encephalopathy (BSE) and a new variant of Creutzfeldt-Jakob disease (nvCJD) that seems to be caused by BSE, there is an increased need for improvement of diagnostic techniques and recognition of all variants of prion diseases in humans and animals. Publications on the immunohistochemical identification of PrP(Sc) in the tonsils and appendix in the incubation period of nvCJD indicate that new and more sensitive techniques for the detection of PrP(Sc) in various tissues may be a valuable tool for early diagnosis in prion diseases. We developed a new and sensitive technique to detect PrP(Sc) in formalin-fixed and paraffin-embedded tissue, the paraffin-embedded tissue blot (PET blot), and reinvestigated archival brain material from CJD as well as BSE and scrapie. In addition, C57/Bl6 mice experimentally infected with the ME7 strain were investigated sequentially during the incubation time to compare this new technique with conventional methodologies. The PET blot detects PrP(Sc) in idiopathic (sporadic) and acquired prion diseases, even in cases with equivocal or negative immunohistochemistry, and is more sensitive than the conventional Western blot and histoblot techniques. The PET blot makes possible the detection of PrP(Sc) during the incubation period long before the onset of clinical disease and in prion disease variants with very low levels of PrP(Sc). In mice experimentally infected with the ME7 strain, the PET blot detects PrP(Sc) in the brain 30 days after intracerebral inoculation-145 days before the onset of clinical signs. Its anatomical resolution is superior to that of the histoblot technique. It may therefore be of particular interest in biopsy diagnosis. Thus it complements other tissue-based techniques for the diagnosis of prion diseases in humans and animals.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10623653      PMCID: PMC1868648          DOI: 10.1016/S0002-9440(10)64705-0

Source DB:  PubMed          Journal:  Am J Pathol        ISSN: 0002-9440            Impact factor:   4.307


  13 in total

1.  Regional mapping of prion proteins in brain.

Authors:  A Taraboulos; K Jendroska; D Serban; S L Yang; S J DeArmond; S B Prusiner
Journal:  Proc Natl Acad Sci U S A       Date:  1992-08-15       Impact factor: 11.205

2.  Preclinical test for prion diseases.

Authors:  B E Schreuder; L J van Keulen; M E Vromans; J P Langeveld; M A Smits
Journal:  Nature       Date:  1996-06-13       Impact factor: 49.962

3.  Diagnostic criteria for sporadic Creutzfeldt-Jakob disease.

Authors:  H A Kretzschmar; J W Ironside; S J DeArmond; J Tateishi
Journal:  Arch Neurol       Date:  1996-09

4.  Prion immunoreactivity in appendix before clinical onset of variant Creutzfeldt-Jakob disease.

Authors:  D A Hilton; E Fathers; P Edwards; J W Ironside; J Zajicek
Journal:  Lancet       Date:  1998-08-29       Impact factor: 79.321

5.  Molecular basis of phenotypic variability in sporadic Creutzfeldt-Jakob disease.

Authors:  P Parchi; R Castellani; S Capellari; B Ghetti; K Young; S G Chen; M Farlow; D W Dickson; A A Sima; J Q Trojanowski; R B Petersen; P Gambetti
Journal:  Ann Neurol       Date:  1996-06       Impact factor: 10.422

6.  Diagnosis of new variant Creutzfeldt-Jakob disease by tonsil biopsy.

Authors:  A F Hill; M Zeidler; J Ironside; J Collinge
Journal:  Lancet       Date:  1997-01-11       Impact factor: 79.321

7.  Mouse polyclonal and monoclonal antibody to scrapie-associated fibril proteins.

Authors:  R J Kascsak; R Rubenstein; P A Merz; M Tonna-DeMasi; R Fersko; R I Carp; H M Wisniewski; H Diringer
Journal:  J Virol       Date:  1987-12       Impact factor: 5.103

8.  A simple and effective method for inactivating virus infectivity in formalin-fixed tissue samples from patients with Creutzfeldt-Jakob disease.

Authors:  P Brown; A Wolff; D C Gajdusek
Journal:  Neurology       Date:  1990-06       Impact factor: 9.910

9.  Replication of distinct scrapie prion isolates is region specific in brains of transgenic mice and hamsters.

Authors:  R Hecker; A Taraboulos; M Scott; K M Pan; S L Yang; M Torchia; K Jendroska; S J DeArmond; S B Prusiner
Journal:  Genes Dev       Date:  1992-07       Impact factor: 11.361

10.  Abnormal isoform of prion proteins accumulates in the synaptic structures of the central nervous system in patients with Creutzfeldt-Jakob disease.

Authors:  T Kitamoto; R W Shin; K Doh-ura; N Tomokane; M Miyazono; T Muramoto; J Tateishi
Journal:  Am J Pathol       Date:  1992-06       Impact factor: 4.307

View more
  81 in total

1.  Molecular changes of preclinical scrapie can be detected by infrared spectroscopy.

Authors:  Janina Kneipp; Michael Beekes; Peter Lasch; Dieter Naumann
Journal:  J Neurosci       Date:  2002-04-15       Impact factor: 6.167

2.  Disease-associated prion protein in vessel walls.

Authors:  Oskar Koperek; Gábor G Kovács; Diane Ritchie; James W Ironside; Herbert Budka; Georg Wick
Journal:  Am J Pathol       Date:  2002-12       Impact factor: 4.307

3.  Agent strain variation in human prion disease: insights from a molecular and pathological review of the National Institutes of Health series of experimentally transmitted disease.

Authors:  Piero Parchi; Maura Cescatti; Silvio Notari; Walter J Schulz-Schaeffer; Sabina Capellari; Armin Giese; Wen-Quan Zou; Hans Kretzschmar; Bernardino Ghetti; Paul Brown
Journal:  Brain       Date:  2010-09-07       Impact factor: 13.501

Review 4.  Paraffin-embedded tissue (PET) blot method: application to Alzheimer disease.

Authors:  Calvin F Moh; Sandra L Siedlak; Massimo Tabaton; George Perry; Rudy J Castellani; Mark A Smith
Journal:  J Neurosci Methods       Date:  2010-05-16       Impact factor: 2.390

5.  Disease-associated prion protein in neural and lymphoid tissues of mink (Mustela vison) inoculated with transmissible mink encephalopathy.

Authors:  D A Schneider; R D Harrington; D Zhuang; H Yan; T C Truscott; R P Dassanayake; K I O'Rourke
Journal:  J Comp Pathol       Date:  2012-05-16       Impact factor: 1.311

6.  Creutzfeldt-Jakob disease associated with an R148H mutation of the prion protein gene.

Authors:  Bjarne Krebs; Rosa-Maria Lederer; Otto Windl; Eva-Maria Grasbon-Frodl; Inga Zerr; Hans A Kretzschmar
Journal:  Neurogenetics       Date:  2005-03-18       Impact factor: 2.660

7.  Domain-specific Quantification of Prion Protein in Cerebrospinal Fluid by Targeted Mass Spectrometry.

Authors:  Eric Vallabh Minikel; Eric Kuhn; Alexandra R Cocco; Sonia M Vallabh; Christina R Hartigan; Andrew G Reidenbach; Jiri G Safar; Gregory J Raymond; Michael D McCarthy; Rhonda O'Keefe; Franc Llorens; Inga Zerr; Sabina Capellari; Piero Parchi; Stuart L Schreiber; Steven A Carr
Journal:  Mol Cell Proteomics       Date:  2019-09-26       Impact factor: 5.911

8.  In vivo detection of prion amyloid plaques using [(11)C]BF-227 PET.

Authors:  Nobuyuki Okamura; Yusei Shiga; Shozo Furumoto; Manabu Tashiro; Yoshio Tsuboi; Katsutoshi Furukawa; Kazuhiko Yanai; Ren Iwata; Hiroyuki Arai; Yukitsuka Kudo; Yasuhito Itoyama; Katsumi Doh-ura
Journal:  Eur J Nucl Med Mol Imaging       Date:  2009-12-17       Impact factor: 9.236

9.  Rapid disease development in scrapie-infected mice deficient for CD40 ligand.

Authors:  Michael Burwinkel; Anja Schwarz; Constanze Riemer; Julia Schultz; Frank van Landeghem; Michael Baier
Journal:  EMBO Rep       Date:  2004-04-08       Impact factor: 8.807

10.  ApoE distribution and family history in genetic prion diseases in Germany.

Authors:  Anna Krasnianski; Nicolas von Ahsen; Uta Heinemann; Bettina Meissner; Hans A Kretzschmar; Victor W Armstrong; Inga Zerr
Journal:  J Mol Neurosci       Date:  2007-09-11       Impact factor: 3.444

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.